To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Life sciences and real estate to advance Blackstone’s $150bn fundraising goal
While capital raising across strategies 'tends to ebb and flow, the overall path of travel is towards more alternatives', says Blackstone’s president and COO.
